Management of Agitated Aggressive Elderly Inpatients
The best treatment approach for an agitated aggressive elderly inpatient is to first address reversible causes of agitation, then implement non-pharmacological strategies, followed by pharmacological interventions only when necessary, with haloperidol 0.5-1mg orally or subcutaneously being the first-line medication for delirium-related agitation. 1
Initial Assessment and Management
Identify and Treat Underlying Causes
- Address reversible causes of anxiety, delirium, and agitation first by exploring patient concerns, ensuring effective communication, providing adequate lighting, and explaining to caregivers how they can help 1
- Treat specific medical conditions that may cause agitation such as pain, hypoxia, urinary retention, constipation, infections (particularly UTIs and pneumonia), dehydration, and electrolyte disturbances 1
- Evaluate medication side effects that might be contributing to agitation 1
- Assess for sensory impairments (hearing, vision) and address these issues 1
Non-Pharmacological Approaches
Implement verbal de-escalation strategies:
- Respect personal space (maintain two arms' length distance) 1
- Use calm demeanor and facial expressions with unclenched, visible hands 1
- Designate one staff member to interact with the patient to avoid confusing multiple messages 1
- Use simple language and concise sentences, allowing adequate time for the patient to process information 1
- Identify the patient's goals and expectations 1
- Set clear limits and expectations while maintaining respect 1
Environmental modifications:
- Create a calming environment with decreased sensory stimulation 1
- Ensure safety by removing potential weapons or dangerous objects 1
- Modify or eliminate triggers of agitation 1
- Provide orientation cues (clocks, calendars, caregiver identification) 1
- Regulate bowel/bladder function and provide adequate nutrition 1
Pharmacological Management
For Delirium-Related Agitation (Patient Able to Swallow)
- Haloperidol 0.5-1 mg orally at night and every 2 hours when required 1
- Increase dose in 0.5-1 mg increments as required (maximum 10 mg daily, or 5 mg daily in elderly patients) 1
- Consider a higher starting oral dose (1.5-3 mg) if the patient is severely distressed or causing immediate danger to others 1
- Consider adding a benzodiazepine such as lorazepam if the patient remains agitated 1
For Anxiety or Agitation (Patient Able to Swallow)
- Lorazepam 0.25-0.5 mg orally four times a day as required (maximum 2 mg in 24 hours for elderly patients) 1
- Oral tablets can be used sublingually (off-label use) 1
For Delirium-Related Agitation (Unable to Swallow)
- Haloperidol may be administered subcutaneously at the same dose as oral 1
- Alternatively, levomepromazine 6.25-12.5 mg subcutaneously as a starting dose in elderly patients, then hourly as required 1
- Maintain with subcutaneous infusion of 50-200 mg over 24 hours, increased according to response (doses >100 mg over 24 hours should be given under specialist supervision) 1
For Anxiety or Agitation (Unable to Swallow)
- Midazolam 2.5-5 mg subcutaneously every 2-4 hours as required 1
- If needed frequently (more than twice daily), consider a subcutaneous infusion via a syringe driver starting with midazolam 10 mg over 24 hours 1
- Reduce dose to 5 mg over 24 hours if estimated glomerular filtration rate (eGFR) is <30 mL per minute 1
Special Considerations
Dementia-Related Agitation
- For patients with underlying dementia, non-pharmacological approaches should be the first-line treatment 1, 2
- Effective pain management can reduce unnecessary psychotropic prescriptions 1
- If pharmacological treatment is necessary, antipsychotics may provide modest improvement in aggression in the short term (6-12 weeks) but have limited impact on other symptoms of agitation 2
- Be aware that long-term antipsychotic use (>12 weeks) is associated with cumulative risk of severe adverse events, including death 2
Combination Therapy
- The combination of a parenteral benzodiazepine and haloperidol may produce more rapid sedation than monotherapy in acutely agitated psychiatric patients 1
- Consider midazolam alone or in combination with levomepromazine if the patient also has anxiety 1
Monitoring and Follow-up
- Regularly reassess mental status as changes may wax and wane 1
- Monitor for medication side effects, particularly extrapyramidal symptoms with antipsychotics 1
- Limit the use of chemical and physical restraints to only those situations in which they are absolutely necessary 1
Common Pitfalls to Avoid
- Failing to identify and treat underlying medical causes of agitation 1
- Using high doses of medications in elderly patients without appropriate dose adjustments 1
- Prolonged use of antipsychotics beyond 12 weeks without reassessment 2
- Neglecting non-pharmacological approaches before initiating medications 1, 2
- Using multiple medications simultaneously without clear indications 1